Aerozolized colistin therapy in non-cystic fibrosis patients with bronchiectasis

P. Lambrou, V. Psalida, G. Koupari, E. Papadaki, S. Parastatides, A. Haniotou, A. Damianos (Athens, Greece)

Source: Annual Congress 2001 - Experimental and clinical models in immuno-pharmacology
Session: Experimental and clinical models in immuno-pharmacology
Session type: Thematic Poster Session
Number: 1797
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Lambrou, V. Psalida, G. Koupari, E. Papadaki, S. Parastatides, A. Haniotou, A. Damianos (Athens, Greece). Aerozolized colistin therapy in non-cystic fibrosis patients with bronchiectasis. Eur Respir J 2001; 16: Suppl. 31, 1797

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effects of long-term azithromycin treatment in patients with non-cystic fibrosis stable bronchiectasis
Source: Annual Congress 2007 - Infectious lung and pleural diseases
Year: 2007


Resistance to antimicrobial agents in patients with non-cystic fibrosis (CF) bronchiectasis
Source: Eur Respir J 2005; 26: Suppl. 49, 640s
Year: 2005

Non-cystic fibrosis bronchiectasis in children
Source: Virtual Congress 2021 – Posters in paediatric bronchology
Year: 2021


Inhaled steroids in children with non-cystic fibrosis bronchiectasis
Source: Eur Respir J 2004; 24: Suppl. 48, 392s
Year: 2004

Non-cystic fibrosis bronchiectasis
Source: Virtual Congress 2020 – Paediatric year in review
Year: 2020

Non-cystic fibrosis bronchiectasis
Source: Eur Respir Monogr 2017; 77: 38-57
Year: 2017


Immuno-allertypes in non-cystic fibrosis  bronchiectasis
Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Year: 2018

Non-cystic fibrosis bronchiectasis
Source: Eur Respir Monogr 2017; 77: 181-198
Year: 2017


Non-cystic fibrosis bronchiectasis
Source: International Congress 2019 – Recent clinical advances in inhalation therapy
Year: 2019


Once-daily tobramycin in the treatment of adult patients with cystic fibrosis
Source: Eur Respir J 2002; 19: 303-309
Year: 2002



Demographics and characteristics of antibiotic use in non-cystic fibrosis bronchiectasis patients
Source: International Congress 2016 – From pleura to bronchi: new insights
Year: 2016


Nebulized antibiotics in patients with non-cystic fibrosis bronchiectasis ans chronic pseudomonas aeruginosa infection
Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis
Year: 2011


Exercise capacity in patients with cystic fibrosis vs non-cystic fibrosis bronchiectasis
Source: International Congress 2018 – Mechanisms that underlie exercise limitation in various respiratory diseases
Year: 2018

Inhaled colistin following lung transplantation in colonised cystic fibrosis patients
Source: Eur Respir J 2013; 42: 542-544
Year: 2013


Non-cystic fibrosis bronchiectasis: series of 89 patients
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008


Inhaled antibiotics in non-cystic fibrosis bronchiectasis: better than oral antibiotics?
Source: International Congress 2016 – PG13 Inhaled antibiotics in respiratory infections
Year: 2016



HRCT features in patients with severe asthma and non-cystic fibrosis bronchiectasis.
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020


Survey of microbiology, pseudomonas eradication and antimicrobial prophylaxis in adult patients with non-cystic fibrosis bronchiectasis
Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis
Year: 2011


Retrospective analysis of CT before and after azithromycin therapy in non-cystic fibrosis bronchiectasis using a modified Brody-score
Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges
Year: 2010